Drugs / Cefo-perazone Sulbactum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03784365 | Dec 2018 → Feb 2020 | achalasia | Asian Institute of Gastroenterology, India | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cefo-perazone Sulbactum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03784365 ↗ |
| Route | Intravenous | “intravenous antibiotic” NCT03784365 ↗ |